Maternal and perinatal outcomes in pregnant women with rheumatic diseases treated with biosimilar TNF inhibitors

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Maternal and perinatal outcomes in pregnant women with rheumatic diseases treated with biosimilar TNF inhibitors.pdf		513.99 KB	Adobe PDF	Download

Authors

No safety or efficacy issues arose from using biosimilar TNFi during conception or pregnancy.

Pregnancy Rheumatic disorders Mothers Perinatal period Tumor necrosis factor inhibitors Biosimilar pharmaceuticals

Oxford University Press